Clusterin expression correlates with stage and presence of large cells in mycosis fungoides.
暂无分享,去创建一个
H. Koeppen | L. Medeiros | A. H. Diwan | V. Prieto | M. Duvic | Z. Zuo | J. Plaza | P. Chandra
[1] S. Lade,et al. Long-term outcomes of patients with advanced-stage cutaneous T-cell lymphoma and large cell transformation. , 2008, Blood.
[2] H. Watari,et al. Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy. , 2008, Gynecologic oncology.
[3] Nicola Pimpinelli,et al. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). , 2007, Blood.
[4] L. Thomas,et al. Transformed mycosis fungoides: clinicopathological features and outcome , 2007, The British journal of dermatology.
[5] R. Boldrini,et al. Anaplastic Large Cell Lymphomas: A Study of 75 Pediatric Patients , 2007, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.
[6] A. Lazar,et al. Oral-Cutaneous CD4-Positive T-cell Lymphoma: A Study of Two Patients , 2007, American journal of dermatopathology.
[7] M. Gleave,et al. Expression of clusterin in prostate cancer correlates with Gleason score but not with prognosis in patients undergoing radical prostatectomy without neoadjuvant hormonal therapy. , 2008, Urology.
[8] J. Willis,et al. Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer , 2006, Cell Death and Differentiation.
[9] G. Pinkus,et al. Clusterin, a marker for anaplastic large cell lymphoma immunohistochemical profile in hematopoietic and nonhematopoietic malignant neoplasms. , 2004, American journal of clinical pathology.
[10] M. Laé,et al. Clusterin is widely expressed in systemic anaplastic large cell lymphoma but fails to differentiate primary from secondary cutaneous anaplastic large cell lymphoma. , 2002, American journal of clinical pathology.
[11] L. Medeiros,et al. Clusterin Expression in Malignant Lymphomas: A Survey of 266 Cases , 2002, Modern Pathology.
[12] M. Gleave,et al. Overexpression of clusterin in transitional cell carcinoma of the bladder is related to disease progression and recurrence. , 2002, Urology.
[13] J. Manning,et al. A novel four-color PCR assay to assess T-cell receptor gamma gene rearrangements in lymphoproliferative lesions. , 2001, American journal of clinical pathology.
[14] C. Petito,et al. Overexpression of clusterin in human breast carcinoma. , 2000, The American journal of pathology.
[15] E. Jaffe,et al. Detection of differentially expressed genes in lymphomas using cDNA arrays: identification of clusterin as a new diagnostic marker for anaplastic large-cell lymphomas. , 2000, Blood.
[16] R. Kurzrock,et al. Transformation of mycosis fungoides/Sezary syndrome: clinical characteristics and prognosis. , 1998, Blood.
[17] H. Kerl,et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. , 1997, Blood.
[18] M E Rosenberg,et al. Clusterin: physiologic and pathophysiologic considerations. , 1995, The international journal of biochemistry & cell biology.
[19] O. Blaschuk,et al. Purification and characterization of a cell-aggregating factor (clusterin), the major glycoprotein in ram rete testis fluid. , 1983, The Journal of biological chemistry.